Disposition and bioavailability of various formulations of tetrahydrocannabinol in the rhesus monkey

Disposition and bioavailability of various formulations of tetrahydrocannabinol in the rhesus monkey 10.1002/jps.2600740213.abs Oral Δ9‐tetrahydrocannabinol (THC) in gelatin capsules is under evaluation as an antiemetic agent in cancer patients, but knowledge concerning its bioavailability is incomplete and, furthermore, alternative routes of administration may be desirable. In this study, the disposition of THC was determined in four rhesus monkeys given 2.5‐mg/kg doses using the following routes of administration and formulations: intravenous (iv); orally (po) on a cookie and in gelatin capsules; intramuscularly (im) in Tween‐80 and in Emulphor‐EL620; rectally in various suppository bases. Serum THC concentrations were measured by RIA and analyzed by weighted nonlinear regression. Serum concentrations were best described by a sum of two exponentials with α and β half‐lives (mean ± SD) of 0.74 ± 0.59 and 14.9 ± 12.5 h. Apparent bioavailability (%F ± SD) of various formulations of THC were: gelatin capsules, 26 ± 14; cookie, 89 ± 16; intramuscularly in Tween‐80 and in Emulphor, 39 ± 13 and 102 ± 15, respectively. Using the method of statistical moments, mean residence times in the body (h ± SD) were: intravenous, 6.08 ± 1.60; cookie, 21.92 ± 3.11; gelatin capsule, 26.80 ± 23.61; intramuscularly in Emulphor, 10.92 ± 3.46 (in Tween‐80, not calculated). THC was not bioavailable by the rectal route. We conclude from this study that THC formulated as a gelatin capsule exhibits a low and variable extent of bioavailability and that intramuscular THC may be a useful alternative route of administration since it is more completely bioavailable. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Journal of Pharmaceutical Science Wiley

Disposition and bioavailability of various formulations of tetrahydrocannabinol in the rhesus monkey

Loading next page...
 
/lp/wolters-kluwer-health/disposition-and-bioavailability-of-various-formulations-of-AGo3WV7yyi
Publisher
Wiley
Copyright
Copyright © 1985 Wiley‐Liss, Inc., A Wiley Company
ISSN
0022-3549
eISSN
1520-6017
DOI
10.1002/jps.2600740213
Publisher site
See Article on Publisher Site

Abstract

10.1002/jps.2600740213.abs Oral Δ9‐tetrahydrocannabinol (THC) in gelatin capsules is under evaluation as an antiemetic agent in cancer patients, but knowledge concerning its bioavailability is incomplete and, furthermore, alternative routes of administration may be desirable. In this study, the disposition of THC was determined in four rhesus monkeys given 2.5‐mg/kg doses using the following routes of administration and formulations: intravenous (iv); orally (po) on a cookie and in gelatin capsules; intramuscularly (im) in Tween‐80 and in Emulphor‐EL620; rectally in various suppository bases. Serum THC concentrations were measured by RIA and analyzed by weighted nonlinear regression. Serum concentrations were best described by a sum of two exponentials with α and β half‐lives (mean ± SD) of 0.74 ± 0.59 and 14.9 ± 12.5 h. Apparent bioavailability (%F ± SD) of various formulations of THC were: gelatin capsules, 26 ± 14; cookie, 89 ± 16; intramuscularly in Tween‐80 and in Emulphor, 39 ± 13 and 102 ± 15, respectively. Using the method of statistical moments, mean residence times in the body (h ± SD) were: intravenous, 6.08 ± 1.60; cookie, 21.92 ± 3.11; gelatin capsule, 26.80 ± 23.61; intramuscularly in Emulphor, 10.92 ± 3.46 (in Tween‐80, not calculated). THC was not bioavailable by the rectal route. We conclude from this study that THC formulated as a gelatin capsule exhibits a low and variable extent of bioavailability and that intramuscular THC may be a useful alternative route of administration since it is more completely bioavailable.

Journal

Journal of Pharmaceutical ScienceWiley

Published: Feb 1, 1985

There are no references for this article.

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Search

Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly

Organize

Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.

Access

Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

DeepDyve

Freelancer

DeepDyve

Pro

Price

FREE

$49/month
$360/year

Save searches from
Google Scholar,
PubMed

Create folders to
organize your research

Export folders, citations

Read DeepDyve articles

Abstract access only

Unlimited access to over
18 million full-text articles

Print

20 pages / month

PDF Discount

20% off